Search - tctmd.com

Displaying 381 - 400 of 461

Sort: Relevancy | Date

News Daily News

BRAVE 4: Prasugrel Plus Bivalirudin Fails to Mitigate Stent Thrombosis in STEMI Patients

May 14, 2014

News Daily News

PLATO Substudy: Ticagrelor Reduces Mortality in NSTE-ACS Patients Regardless of Revascularization

L.A. McKeown

April 25, 2014

News Daily News

ARCTIC Analysis: Platelet Function Testing Does Not Enhance Secondary Prevention

Caitlin E. Cox

April 11, 2014

News Daily News

High Prasugrel Loading Dose Limits Platelet Reactivity after Primary PCI for STEMI

Caitlin E. Cox

April 09, 2014

News Conference News ACC 2014

EUROMAX: Bivalirudin May Hold Key to Solving Problem of Early ST After Primary PCI

Jason Kahn

March 29, 2014

News Daily News

FDA Panel Rejects Cangrelor for Both PCI, Bridging Indications

Yael L. Maxwell

February 13, 2014

News Daily News

New PCI Performance Measures Issued to Improve Quality of Care

January 06, 2014

News Conference News TCT 2013

Studies Find Differing Benefits of Platelet, Genotype Testing

October 31, 2013

News Conference News TCT 2013

EUROMAX: Prehospital Bivalirudin Reduces Bleeding in STEMI

October 30, 2013

News Industry News

Study Find Pre-Hospital Administration of Bivalirudin Substantially Improves Outcomes Compared to Heparin in Heart Attack Patients

October 30, 2013

News Daily News

Hypothermia Does Not Increase Stent Thrombosis Risk in Primary PCI Patients

October 16, 2013

News Daily News

Consensus Paper Details Link Between Platelet Reactivity and Ischemia, Bleeding

L.A. McKeown

October 15, 2013

News Daily News

ESC Consensus Statement Outlines Proper Role of Platelet Function Testing After PCI

September 30, 2013

News Daily News

NCDR Registries Give Nationwide Assessment of Cardiovascular Care

September 20, 2013

News Conference News ESC 2013

ACCOAST: Prasugrel Pretreatment Increases Bleeding in NSTE-ACS

Yael L. Maxwell

September 01, 2013

News Daily News

Bleeding Risk of Triple Therapy Not Attenuated by Well-Controlled Warfarin

August 30, 2013

News Daily News

Upstream Eptifibatide Treatment Linked with Better Outcomes in PCI Patients

Yael L. Maxwell

August 19, 2013

News Daily News

No Increased Mortality Risk for DES Patients with High Platelet Reactivity on Clopidogrel

L.A. McKeown

August 12, 2013

News Daily News

Add-on Cilostazol Reduces Restenosis in High-Risk Patients Receiving DES

August 08, 2013

News Daily News

For A-fib Patients, Aspirin on Top of Anticoagulation Raises Bleeding Risk

Caitlin E. Cox

July 25, 2013

Advertisement

BRAVE 4: Prasugrel Plus Bivalirudin Fails to Mitigate Stent Thrombosis in STEMI Patients

PLATO Substudy: Ticagrelor Reduces Mortality in NSTE-ACS Patients Regardless of Revascularization

ARCTIC Analysis: Platelet Function Testing Does Not Enhance Secondary Prevention

High Prasugrel Loading Dose Limits Platelet Reactivity after Primary PCI for STEMI

EUROMAX: Bivalirudin May Hold Key to Solving Problem of Early ST After Primary PCI

FDA Panel Rejects Cangrelor for Both PCI, Bridging Indications

New PCI Performance Measures Issued to Improve Quality of Care

Studies Find Differing Benefits of Platelet, Genotype Testing

EUROMAX: Prehospital Bivalirudin Reduces Bleeding in STEMI

Study Find Pre-Hospital Administration of Bivalirudin Substantially Improves Outcomes Compared to Heparin in Heart Attack Patients

Hypothermia Does Not Increase Stent Thrombosis Risk in Primary PCI Patients

Consensus Paper Details Link Between Platelet Reactivity and Ischemia, Bleeding

ESC Consensus Statement Outlines Proper Role of Platelet Function Testing After PCI

NCDR Registries Give Nationwide Assessment of Cardiovascular Care

ACCOAST: Prasugrel Pretreatment Increases Bleeding in NSTE-ACS

Bleeding Risk of Triple Therapy Not Attenuated by Well-Controlled Warfarin

Upstream Eptifibatide Treatment Linked with Better Outcomes in PCI Patients

No Increased Mortality Risk for DES Patients with High Platelet Reactivity on Clopidogrel

Add-on Cilostazol Reduces Restenosis in High-Risk Patients Receiving DES

For A-fib Patients, Aspirin on Top of Anticoagulation Raises Bleeding Risk

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content